Fresh2 Group Limited (NASDAQ: FRES)
$1.1300
-0.1370 ( -18.71% ) 2.1K
Fresh2 Group Ltd is a biotechnology company. It focuses on early cancer screening and detection. The company markets and sells a multi-cancer screening and detection test that uses its innovative patented CDA technology and its proprietary CDA device. In addition to early cancer screening and detection, its CDA technology has demonstrated the potential to assist physicians in cancer diagnosis, prognosis, and recurrence.
Market Data
Open
$1.1300
Previous close
$1.2665
Volume
2.1K
Market cap
$3.11M
Day range
$1.2560 - $1.3850
52 week range
$0.8536 - $12.7500
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 15 | Mar 25, 2024 |
8-k | 8K-related | 17 | Feb 16, 2024 |
8-k | 8K-related | 16 | Feb 01, 2024 |
8-k | 8K-related | 15 | Jan 29, 2024 |
8-k | 8K-related | 17 | Jan 29, 2024 |
3 | Insider transactions | 1 | Jan 26, 2024 |
3 | Insider transactions | 1 | Jan 26, 2024 |
3 | Insider transactions | 1 | Jan 26, 2024 |
3 | Insider transactions | 1 | Jan 26, 2024 |
3 | Insider transactions | 1 | Jan 26, 2024 |